证券记录 · 已归档季度
GH
Guardant Health, Inc. · Healthcare · Medical - Diagnostics & Research
14被追踪持有人
—Δ持有人
24.13M持有股份
$697.01M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 139 | +11 | 93.68M | $13.96B | +17 | −5 |
| Q1 2026 | 130 | -8 | 97.95M | $8.77B | +5 | −14 |
| Q4 2025 | 137 | +1 | 99.79M | $9.86B | +2 | — |
| Q3 2025 | 22 | +1 | 50.89M | $3.18B | +2 | −2 |
| Q2 2025 | 19 | -1 | 51.15M | $2.66B | — | −1 |
| Q1 2025 | 17 | -1 | 25.07M | $1.07B | — | −1 |
| Q4 2024 | 18 | +2 | 25.10M | $766.76M | +2 | — |
| Q3 2024 | 15 | +1 | 25.31M | $580.70M | +2 | −1 |
| Q2 2024 | 14 | — | 24.13M | $697.01M | — | — |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 6.09M | — | $175.97M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 3.51M | — | $101.33M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 3.29M | — | $95.04M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 3.29M | — | $95.04M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Geode Capital Management ✦ (被动) | 2.79M | — | $80.66M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 2.79M | — | $80.66M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Millennium Management ✦ | 2.14M | — | $61.67M | 0.1% | n/c | 1 | SEC ↗ |
| 14 | Point72 Asset Management ✦ | 1.82M | — | $52.42M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Norges Bank ✦ (被动) | 1.38M | — | $39.96M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 1.38M | — | $39.73M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 1.38M | — | $39.73M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 814.52K | — | $23.52M | 0.1% | n/c | 1 | SEC ↗ |
| 19 | ARK Investment Management ✦ | 453.59K | — | $13.10M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 299.80K | — | $8.66M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 84.75K | — | $2.45M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | PRIMECAP Management ✦ | 66.18K | — | $1.91M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Bridgewater Associates ✦ | 20.20K | — | $583,405 | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 481 持有人, 137.05M 股份, $11.53B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Aug 21
Talasaz AmirAli
Officer, Director · 20.89K 股 · $3.53M
Aug 21
Talasaz AmirAli
Officer, Director · 7.59K 股 · $1.29M
Aug 21
Talasaz AmirAli
Officer, Director · 9.02K 股 · $1.52M
Aug 17
Tariq Musa
Director · 116 股 · $18,148
Aug 12
Monroe Terilyn J.
Officer · 13.25K 股 · $2.20M
Aug 12
Monroe Terilyn J.
Officer · 3.70K 股 · $605,286
Aug 12
Monroe Terilyn J.
Officer · 9.93K 股 · $1.63M
Aug 12
Monroe Terilyn J.
Officer · 19.01K 股 · $3.14M
Aug 12
Monroe Terilyn J.
Officer · 400 股 · $67,168
Aug 10
Freeman Chris
Officer · 3.46K 股 · $579,639
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Aug 14
SC 13G/A — PRICE T ROWE ASSOCIATES INC /MD/
Jul 28
SC 13G/A — BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据